What If Ventures

Kindbody is a fertility clinic network and family-building benefits provider for employers offering comprehensive virtual and in-person care. Kindbody's clinically-managed program includes fertility assessments and education, fertility preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption. Employers partner with Kindbody to provide their employees with financial, medical, and emotional support as they pursue parenthood. Kindbody is the trusted fertility benefits provider for more than 100 employers, covering more than 2.4 million lives. Many thousands more receive their fertility care directly from Kindbody throughout the country at Kindbody’s network of signature clinics, mobile clinics, and partner clinics.

Mate Fertility operates tech-enabled fertility clinics that offer affordable and accessible fertility services. The company also offers a platform that provides access to fertility clinics and telemedicine for fertility treatments and therapies. Mate Fertility was founded in 2020 and is headquartered in Los Angeles, California.

Mimio Health is a nutraceutical company focusing on the research and production of mimetic supplements. Its patent-pending fasting mimetic formulation uses a rigorously selected combination of the same bioactive human metabolites that induce this regenerative "bio-program" to replicate the body’s natural response to fasting without having to fast.

Carbon Health is a tech-enabled healthcare company that delivers virtual care experience. It offers primary care services through a mobile application that enables users to follow up on a treatment plan, manage prescriptions, and see lab reports all through one app. Carbon Health has created a coronavirus assessment tool and also set up covid-19 testing in California. The company was founded in 2015 and is headquartered in San Francisco, California.

Affect Therapeutics offers an integrated digital treatment program for drug and alcohol addiction via a mobile app. They provide treatments for a variety of substance use disorders. The program provides financial incentives to encourage healthy behaviors and new habits.

Maximus is a consumer telemedicine company for men’s health and hormone optimization. Maximus is revolutionizing the performance enhancement space by democratizing doctor-prescribed protocols developed by some of the world’s leading experts in men’s health. Maximus’ King Protocol utilizes a convenient prescription medication capsule to stimulate natural testosterone production, proven by at-home lab tests. Maximus was established in 2020 by Cameron Sepah in Santa Monica, California.

Foresight is a technology-enabled psychiatry and therapy services company. We directly employ psychiatrists, therapists, psychiatric nurse practitioners to treat patients in our offices. Our team of software and biomedical engineers create technology alongside our providers to revolutionize the care we provide.

Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.

Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan.

Mightier is a gaming platform and family program scientifically-proven to help kids regulate their emotions. It is a bioresponsive program that harnesses the mind-body connection to build emotional regulation in its players. Its program of bioresponsive video games, developed at Boston Children's Hospital and Harvard Medical School, aims to help children with behavioral and emotional challenges learn how to harness emotions in daily life. Mightier was founded in 2016 and is headquartered in Boston, Massachusetts.

Aptihealth is a behavioral health engagement company that uses technology to seamlessly integrate physical and behavioral healthcare. Its groundbreaking platform connects medical providers, behavioral health specialists, behavioral health prescribers, and patients with its proprietary screening, assessment, and treatment management protocols. Aptihealth’s digital platform provides a seamless and effective approach to virtual, intelligent integrated care that helps patients get better faster and stay better longer. Aptihealth provides those in need of behavioral healthcare with a fast track to better mental health.

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality. By creating a new medical modality of remote-controlled micro-robots called Bionauts, the company can transform the way the biopharmaceutical industry develops treatments, allowing them to engineer the therapeutic index for efficacy and maintain safety. Bionaut Labs is focused on helping patients suffering from debilitating brain diseases who have few available treatment options. The anatomical targeting capabilities of the Bionaut platform make new therapeutics technologies such as gene therapy, CRISPR-Cas9, and oncolytic viruses viable in challenging clinical settings.

Jane Technologies is a cannabis retail tech company that provides its consumers with a confident, safe and simple shopping experience. Users can browse local products in real-time, compare by price, proximity or popularity and place orders at local stores for free. Jane partners with dispensaries on a win-win basis; stores only pay for completed orders at a fraction of the price of other industry software.

MiResource is working to make the world a mentally healthier place by connecting people with mental healthcare. We envision a world where every young person can access effective mental healthcare.

Woebot Health is a mental healthcare center for people and businesses. Their behavioral health platform combines sophisticated AI, decades of clinically-proven therapeutic research, and an engaging relational agent called Woebot, which together form the foundation for delivering continuous care via purely digital, empathic, and personalized apps that are easy to talk to and fit right into people’s lives.

Psilera is a biopharmaceutical company focused on developing groundbreaking therapeutics for neurodegenerative diseases by creating a new class of neurological medicines. Psilera's lead asset, PSIL-006, is a non-hallucinogenic psilocybin derivative for the treatment of frontotemporal dementia (FTD). With a deep commitment to improving the patient experience through scientific excellence, Psilera is transforming the lives of individuals affected by devastating diseases. Welcome to the new era of mindful medicine.

TRIPP is a digital psychedelic wellness platform that uses the power of virtual and augmented reality. TRIPP creates advanced digital products that are based on scientific research and delivered through virtual reality, augmented reality, and mobile devices. TRIPP's platform is currently delivering wellness solutions to consumer households. It was founded in 2017 and headquartered in Los Angeles, California.

Ksana Health focuses on collecting data related to mental health and transferring that data from users to healthcare practitioners through an app. It was founded in 2019 and is based in Eugene, Oregon.

Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose is to accelerate treatments and fundamentally improve mental health.

Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most.

Beckley Psytech operates as a psychedelic medicine company. The company is involved in exploring the therapeutic potential of psychedelic substances, such as psilocybin and other compounds, for mental health treatment. The company envisions the integration of clinically validated psychedelic medicines into contemporary medical practices to assist individuals coping with depression and other significantly debilitating neuropsychiatric conditions characterized by a substantial unmet need.

Peachy Patients offers a tool designed to make healthcare affordable and accessible to patients. It enables patients to pay their medical bills in one place, earn cash-back on every dollar spent, and be confident that they are always paying the correct price. The Peachy Patients platform puts patients at the center of the healthcare experience, providing them with the tools and resources they need to access care at a reasonable cost.

NeuroFlow is a platform to be a resource and asset to healthcare providers in their pursuit to get patients better and improve lives. It is a cloud-based platform that empowers healthcare providers to track, assess, and engage patients using evidence-based practices to support their mental health. The suite of tools supports remote monitoring and behavioral health integration across the continuum of care, including psychology, primary care, and pain management settings, to increase patient engagement and improve compliance.

Atai Life Sciences is a biotechnology company that develops therapies for mental health disorders. The company focuses on creating treatments using psychedelic compounds and other methods to address conditions such as depression, anxiety, and substance use disorders. Atai collaborates with various partners and research institutions to advance its drug development pipeline, which includes several clinical-stage programs. The product portfolio includes therapies that utilize research in psychedelics and neuroscience. Atai's lead programs feature ketamine-based treatments and other compounds aimed at improving mental well-being. The company works with experts in the field to ensure the efficacy and safety of its therapies. Atai Life Sciences has received recognition for its work in mental health treatment, securing partnerships and funding to support its research initiatives. The company has been acknowledged for its contributions to psychiatry and has gained attention for its efforts to advance the understanding and treatment of mental health disorders.

Foresight is a technology-enabled psychiatry and therapy services company. We directly employ psychiatrists, therapists, psychiatric nurse practitioners to treat patients in our offices. Our team of software and biomedical engineers create technology alongside our providers to revolutionize the care we provide.